To Assess the Safety, Tolerability and Pharmacokinetics of AZD2820 After Single Ascending Doses
Clinical trial NCT01332214 · COMPLETED
Trial details
- NCT number
- NCT01332214
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2011-11-01
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.